Get the latest news on IR Biosciences Holdings stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on IRBS performance

Latest IR Biosciences Holdings Stock News | OTC:IRBS | Benzinga

IR Biosciences Holdings Inc is a development-stage biotechnology company engaged in the research & development of potential drug candidate, Homspera and its derivatives, Radilex and Viprovex through its subsidiary, ImmuneRegen BioSciences, Inc. It is engaged in the research and development of therapies in the areas of pulmonary fibrosis, influenza infection, and radiation-induced Neutropenia.

IR BIOSCIENCES HLDGS INC by IR Biosciences Holdings, Inc.

Comments

IR Biosciences Holdings Stock News

News

Latest IR Biosciences Holdings Stock News | OTC:IRBS | Benzinga

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga